On July 27, Beijing Scitop Bio-tech Co., Ltd (Stock abbreviation, Stock Code: 300858) successfully listed on the Growth Enterprise Market of Shenzhen Stock Exchange and issued 20.63 million A-shares at an initial public offering price of 23.7 yuan/share, raising A total of 489 million yuan.
It rose 44.01% on its first day of trading, and then rose by the daily limit again on July 28. The current share price is 37.54 yuan/share, with a total market value of about 3.1 billion yuan.
Scitop Bio is a high-tech enterprise mainly engaged in the research, development, production and sales of compound food additives and probiotics products as well as animal and plant microecological preparations. Its revenue in 2017-2019 was 284 million yuan 318 million yuan and 308 million yuan respectively.
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
